PATH MER Indicators, published by PATH. This is not an authorized publication; it is the continuous build for version 0.1.0). This version is based on the current content of https://github.com/PATH-Global-Health/MERindicators and changes regularly. See the Directory of published versions
: ICD-11 codes from the HIV DAK - XML Representation
Raw xml | Download
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="DAKICD11"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This case-insensitive code system <code>http://hl7.org/fhir/sid/icd-11</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">1C62.0<a name="DAKICD11-1C62.460"> </a></td><td>HIV disease clinical stage 1 without mention of tuberculosis or malaria</td></tr><tr><td style="white-space:nowrap">1C62.1<a name="DAKICD11-1C62.461"> </a></td><td>HIV disease clinical stage 2 without mention of tuberculosis or malaria</td></tr><tr><td style="white-space:nowrap">1C62.2<a name="DAKICD11-1C62.462"> </a></td><td>HIV disease clinical stage 3 without mention of tuberculosis or malaria</td></tr><tr><td style="white-space:nowrap">1C62.3<a name="DAKICD11-1C62.463"> </a></td><td>HIV disease clinical stage 4 without mention of tuberculosis or malaria</td></tr><tr><td style="white-space:nowrap">1C62.Z<a name="DAKICD11-1C62.46Z"> </a></td><td>Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified</td></tr><tr><td style="white-space:nowrap">XM63K0<a name="DAKICD11-XM63K0"> </a></td><td>Anti-infective antiviral</td></tr><tr><td style="white-space:nowrap">QA14<a name="DAKICD11-QA14"> </a></td><td>Contact with health services for human immunodeficiency virus counselling</td></tr><tr><td style="white-space:nowrap">XM35P4<a name="DAKICD11-XM35P4"> </a></td><td>Abacavir</td></tr><tr><td style="white-space:nowrap">XM2L06<a name="DAKICD11-XM2L06"> </a></td><td>Emtricitabine</td></tr><tr><td style="white-space:nowrap">XM5471<a name="DAKICD11-XM5471"> </a></td><td>Lamivudine</td></tr><tr><td style="white-space:nowrap">XM9C07<a name="DAKICD11-XM9C07"> </a></td><td>Zidovudine</td></tr><tr><td style="white-space:nowrap">XM8Z78<a name="DAKICD11-XM8Z78"> </a></td><td>Didanosine</td></tr><tr><td style="white-space:nowrap">XM7RM1<a name="DAKICD11-XM7RM1"> </a></td><td>Stavudine</td></tr><tr><td style="white-space:nowrap">XM67N3<a name="DAKICD11-XM67N3"> </a></td><td>Tenofovir disoproxil</td></tr><tr><td style="white-space:nowrap">XM1DX2<a name="DAKICD11-XM1DX2"> </a></td><td>Efavirenz</td></tr><tr><td style="white-space:nowrap">XM7N44<a name="DAKICD11-XM7N44"> </a></td><td>Etravirine</td></tr><tr><td style="white-space:nowrap">XM10T5<a name="DAKICD11-XM10T5"> </a></td><td>Nevirapine</td></tr><tr><td style="white-space:nowrap">XM1KD4<a name="DAKICD11-XM1KD4"> </a></td><td>Rilpivirine</td></tr><tr><td style="white-space:nowrap">XM4TF3<a name="DAKICD11-XM4TF3"> </a></td><td>Atazanavir and Ritonavir</td></tr><tr><td style="white-space:nowrap">XM3EH7<a name="DAKICD11-XM3EH7"> </a></td><td>Lopinavir and Ritonavir</td></tr><tr><td style="white-space:nowrap">XM8ZN1<a name="DAKICD11-XM8ZN1"> </a></td><td>Darunavir and Ritonavir</td></tr><tr><td style="white-space:nowrap">XM56L1<a name="DAKICD11-XM56L1"> </a></td><td>Ritonavir</td></tr><tr><td style="white-space:nowrap">XM6K45<a name="DAKICD11-XM6K45"> </a></td><td>Dolutegravir</td></tr><tr><td style="white-space:nowrap">XM82D3<a name="DAKICD11-XM82D3"> </a></td><td>Raltegravir</td></tr><tr><td style="white-space:nowrap">XM8QY9<a name="DAKICD11-XM8QY9"> </a></td><td>Lamivudine, Tenofovir disoproxil and Dolutegravir</td></tr><tr><td style="white-space:nowrap">XM3U67<a name="DAKICD11-XM3U67"> </a></td><td>Antivirals for treatment of human immunodeficiency virus infections, combinations best fit</td></tr><tr><td style="white-space:nowrap">XM9NL2<a name="DAKICD11-XM9NL2"> </a></td><td>Lamivudine, Tenofovir disoproxil and Efavirenz</td></tr><tr><td style="white-space:nowrap">XM2UU9<a name="DAKICD11-XM2UU9"> </a></td><td>Lamivudine, Abacavir and Dolutegravir</td></tr></table></div>
</text>
<url value="http://hl7.org/fhir/sid/icd-11"/>
<version value="0.1.0"/>
<name value="DAKICD11"/>
<title value="ICD-11 codes from the HIV DAK"/>
<status value="draft"/>
<experimental value="false"/>
<date value="2023-10-19T20:59:19+00:00"/>
<publisher value="PATH"/>
<contact>
<name value="PATH"/>
<telecom>
<system value="url"/>
<value value="https://www.path.org"/>
</telecom>
<telecom>
<system value="email"/>
<value value="info@path.org"/>
</telecom>
</contact>
<contact>
<name value="PATH"/>
<telecom>
<system value="email"/>
<value value="info@path.org"/>
<use value="work"/>
</telecom>
</contact>
<description value="ICD-11 codes from the HIV DAK"/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
<display value="World"/>
</coding>
</jurisdiction>
<caseSensitive value="false"/>
<content value="complete"/>
<count value="28"/>
<concept>
<code value="1C62.0"/>
<display
value="HIV disease clinical stage 1 without mention of tuberculosis or malaria"/>
</concept>
<concept>
<code value="1C62.1"/>
<display
value="HIV disease clinical stage 2 without mention of tuberculosis or malaria"/>
</concept>
<concept>
<code value="1C62.2"/>
<display
value="HIV disease clinical stage 3 without mention of tuberculosis or malaria"/>
</concept>
<concept>
<code value="1C62.3"/>
<display
value="HIV disease clinical stage 4 without mention of tuberculosis or malaria"/>
</concept>
<concept>
<code value="1C62.Z"/>
<display
value="Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified"/>
</concept>
<concept>
<code value="XM63K0"/>
<display value="Anti-infective antiviral"/>
</concept>
<concept>
<code value="QA14"/>
<display
value="Contact with health services for human immunodeficiency virus counselling"/>
</concept>
<concept>
<code value="XM35P4"/>
<display value="Abacavir"/>
</concept>
<concept>
<code value="XM2L06"/>
<display value="Emtricitabine"/>
</concept>
<concept>
<code value="XM5471"/>
<display value="Lamivudine"/>
</concept>
<concept>
<code value="XM9C07"/>
<display value="Zidovudine"/>
</concept>
<concept>
<code value="XM8Z78"/>
<display value="Didanosine"/>
</concept>
<concept>
<code value="XM7RM1"/>
<display value="Stavudine"/>
</concept>
<concept>
<code value="XM67N3"/>
<display value="Tenofovir disoproxil"/>
</concept>
<concept>
<code value="XM1DX2"/>
<display value="Efavirenz"/>
</concept>
<concept>
<code value="XM7N44"/>
<display value="Etravirine"/>
</concept>
<concept>
<code value="XM10T5"/>
<display value="Nevirapine"/>
</concept>
<concept>
<code value="XM1KD4"/>
<display value="Rilpivirine"/>
</concept>
<concept>
<code value="XM4TF3"/>
<display value="Atazanavir and Ritonavir"/>
</concept>
<concept>
<code value="XM3EH7"/>
<display value="Lopinavir and Ritonavir"/>
</concept>
<concept>
<code value="XM8ZN1"/>
<display value="Darunavir and Ritonavir"/>
</concept>
<concept>
<code value="XM56L1"/>
<display value="Ritonavir"/>
</concept>
<concept>
<code value="XM6K45"/>
<display value="Dolutegravir"/>
</concept>
<concept>
<code value="XM82D3"/>
<display value="Raltegravir"/>
</concept>
<concept>
<code value="XM8QY9"/>
<display value="Lamivudine, Tenofovir disoproxil and Dolutegravir"/>
</concept>
<concept>
<code value="XM3U67"/>
<display
value="Antivirals for treatment of human immunodeficiency virus infections, combinations best fit"/>
</concept>
<concept>
<code value="XM9NL2"/>
<display value="Lamivudine, Tenofovir disoproxil and Efavirenz"/>
</concept>
<concept>
<code value="XM2UU9"/>
<display value="Lamivudine, Abacavir and Dolutegravir"/>
</concept>
</CodeSystem>
|